Skip to main content
All lobbying filings

FORBES-TATE

FORBES-TATE filed a Q3 report for GRAIL, INC. on October 18, 2026, reporting $50,000 in lobbying income.

Lobbying for GRAIL, INC. · Biotechnology Company

All filings by FORBES-TATE · Everything GRAIL, INC. has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 18, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2

Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.

Healthcare issues regarding oncology and early multi-cancer detection, including diagnostics and screening; Medicare issues regarding oncology and early multi-cancer detection, including diagnostics and screening.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem